Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-11 8:39 pm Purchase |
2025-06-09 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 2,779,385 37.900% |
1,417,209 (+104.04%) |
Filing History |
| 2025-05-15 9:13 pm Purchase |
2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 398,122 9.600% |
55,683 (+16.26%) |
Filing History |
| 2025-05-15 4:42 pm Purchase |
2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA |
Konar Shameek | 229,020 5.500% |
229,020 (New Position) |
Filing History |
| 2025-05-14 8:39 pm Purchase |
2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA |
IAF, LLC | 217,028 5.200% |
38,414 (+21.51%) |
Filing History |
| 2025-05-14 2:14 pm Purchase |
2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 414,102 9.900% |
71,656 (+20.92%) |
Filing History |
| 2025-04-04 10:55 am Purchase |
2025-04-02 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 1,362,176 32.800% |
252,697 (+22.78%) |
Filing History |
| 2025-03-05 5:55 pm Purchase |
2024-10-29 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 1,109,479 32.380% |
1,028,644 (+1272.52%) |
Filing History |
| 2025-02-14 9:30 pm Purchase |
2024-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 171,000 4.920% |
130,968 (+327.16%) |
Filing History |
| 2025-02-14 8:36 pm Purchase |
2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 342,439 9.990% |
342,439 (New Position) |
Filing History |
| 2025-02-12 5:54 pm Purchase |
2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA |
IAF, LLC | 178,614 5.220% |
140,150 (+364.36%) |
Filing History |
| 2025-01-28 5:31 pm Purchase |
2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 342,446 9.990% |
272,214 (+387.59%) |
Filing History |
| 2024-01-31 07:05 am Purchase |
2023-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 36,726 9.990% |
6,574 (+21.80%) |
Filing History |
| 2024-01-19 10:31 am Purchase |
2023-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 40,032 9.990% |
2,871 (+7.73%) |
Filing History |
| 2023-12-22 12:05 pm Unchanged |
2023-12-14 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 80,835 19.990% |
0 (Unchanged) |
Filing History |
| 2023-12-20 3:24 pm Purchase |
2023-12-14 | 13G | Eterna Therapeutics Inc. ERNA |
IAF, LLC | 38,464 9.990% |
38,464 (New Position) |
Filing History |
| 2023-09-08 06:07 am Unchanged |
2023-07-06 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 37,161 9.900% |
0 (Unchanged) |
Filing History |
| 2023-09-07 5:26 pm Purchase |
2023-07-13 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 80,835 19.990% |
43,000 (+113.65%) |
Filing History |
| 2023-08-28 4:57 pm Purchase |
2023-04-03 | 13G | Eterna Therapeutics Inc. ERNA |
Purchase Capital LLC | 18,695 5.000% |
18,695 (New Position) |
Filing History |
| 2023-07-26 5:05 pm Purchase |
2023-04-03 | 13D | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 37,161 9.990% |
37,161 (New Position) |
Filing History |
| 2023-07-20 7:52 pm Purchase |
2023-07-14 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 70,232 19.990% |
23,732 (+51.04%) |
Filing History |